- Home
- UAL vs GEHC Comparison
UAL vs GEHC Comparison
Compare UAL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAL | GEHC |
|---|---|---|
| Founded | 1934 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.0B | 33.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UAL | GEHC |
|---|---|---|
| Price | $106.27 | $83.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $127.17 | $85.89 |
| AVG Volume (30 Days) | ★ 5.7M | 4.3M |
| Earning Date | 01-20-2026 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | 20.30 | ★ 32.35 |
| EPS | ★ 9.99 | 4.83 |
| Revenue | ★ $58,369,000,000.00 | $20,246,000,000.00 |
| Revenue This Year | $4.70 | $6.33 |
| Revenue Next Year | $7.65 | $4.38 |
| P/E Ratio | ★ $10.58 | $17.19 |
| Revenue Growth | ★ 4.24 | 3.51 |
| 52 Week Low | $52.00 | $57.65 |
| 52 Week High | $116.00 | $94.80 |
Technical Indicators
Market Signals| Indicator | UAL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 62.70 |
| Support Level | $103.04 | $82.47 |
| Resistance Level | $109.66 | $85.89 |
| Average True Range (ATR) | 3.66 | 2.33 |
| MACD | 1.00 | 0.68 |
| Stochastic Oscillator | 79.68 | 80.43 |
Price Performance
Historical ComparisonAbout UAL United Airlines Holdings Inc.
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).